Literature DB >> 24070008

Hydroxylated bisabolol oxides: evidence for secondary oxidative metabolism in Matricaria chamomilla.

Cristina Avonto1, Mei Wang, Amar G Chittiboyina, Bharathi Avula, Jianping Zhao, Ikhlas A Khan.   

Abstract

German chamomile (Matricaria chamomilla) is one of the most popular medicinal plants used in Western herbal medicine. Among the various phytochemicals present in the essential oil of the flowers of German chamomile, bisabolol and its oxidized metabolites are considered as marker compounds for distinguishing different chemotypes. These compounds are influential in mediating the aroma of the essential oil of M. chamomilla and contribute to the therapeutic properties (anti-inflammatory, antibacterial, insecticidal, and antiulcer) of this species. In order to find other possible bisabolol derivatives as marker compounds for authentication of German chamomile in botanical and commercial products, an in-depth investigation using a GC-assisted fractionation procedure was performed on nonpolar fractions. As a result of this approach, three new hydroxylated derivatives of bisabolol oxides A and B (1-3) have been isolated from M. chamomilla. Plausible biogenetic pathways are presented.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24070008     DOI: 10.1021/np4003349

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  3 in total

Review 1.  A systematic review study of therapeutic effects of Matricaria recuitta chamomile (chamomile).

Authors:  Sepide Miraj; Samira Alesaeidi
Journal:  Electron Physician       Date:  2016-09-20

2.  Isolation of sesquiterpenoids from Matricaria chamomilla by means of solvent assisted flavor evaporation and centrifugal partition chromatography.

Authors:  Benedikt Slavik; Simon Roehrer; Helene M Loos; Mirjana Minceva; Andrea Buettner
Journal:  Anal Bioanal Chem       Date:  2021-05-28       Impact factor: 4.142

Review 3.  Herbal Medicines-Are They Effective and Safe during Pregnancy?

Authors:  Beata Sarecka-Hujar; Beata Szulc-Musioł
Journal:  Pharmaceutics       Date:  2022-01-12       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.